New Data: Is Your Early Hemoglobin Level Too High or Too Low?

\n

Anemia impacts up to half of all pregnancies globally, presenting a critical public health challenge, particularly in South Asia. Notably, this includes India, where the prevalence of anemia in pregnancy remains significantly high. Consequently, research into optimal maternal iron status is vital for improving perinatal outcomes. A recent large, population-based cohort study now provides crucial insight into the relationship between Early Pregnancy Hemoglobin (Hb) levels and severe neonatal morbidity and mortality (SNM-M).

\n

The U-Shaped Risk: Anemia and Relative Erythrocytosis

\n

Researchers in Canada studied over one million births to analyze the nonlinear association between Hb concentration and SNM-M, measuring Hb at 2 to 12 weeks' gestation. Furthermore, the extensive study confirmed a definitive U-shaped relationship with adverse outcomes. Therefore, both maternal anemia and relative erythrocytosis were associated with increased neonatal morbidity and mortality. For instance, a hemoglobin concentration of 105 g/L (anemia) resulted in an adjusted Relative Risk (aRR) for SNM-M of 1.08. However, an Hb level of 150 g/L (relative erythrocytosis) was linked to an even higher aRR of 1.20, compared to the reference value of 125 g/L. Conversely, other large-scale reviews spanning multiple studies also show that anemia significantly increases the risk of low birth weight, preterm birth, and perinatal mortality in South Asian populations.

\n

Addressing the Optimal Early Pregnancy Hemoglobin Range

\n

The findings strongly suggest that the "sweet spot" for maternal Hb in early pregnancy may be narrower than previously assumed. Consequently, practitioners must recognize that high Hb levels—not just low levels—warrant further investigation. In fact, a rise in the aRR was also observed at 135 g/L (aRR 1.05). Clinicians should therefore aim for a balanced Hb level rather than simply over-correcting anemia. The limitations of the initial study included not knowing the iron replacement status of the women before or during pregnancy. This is a critical factor for Indian practitioners, who routinely prescribe Iron and Folic Acid (IFA) supplements starting after the first trimester. Therefore, the authors recommend that future randomized clinical trials (RCTs) specifically evaluate the precise effect of iron therapy on perinatal outcomes based on the degree of Hb correction. Ultimately, this research calls for a re-evaluation of treatment goals beyond the traditional focus on only addressing anemia.

\n

Frequently Asked Questions

\n

Q1: What is the primary clinical finding of this study regarding Early Pregnancy Hemoglobin?

\n

The study found a U-shaped relationship between early pregnancy hemoglobin (Hb) concentration and severe neonatal morbidity and mortality (SNM-M). This means that both low Hb (maternal anemia) and high Hb (relative erythrocytosis) are associated with an increased risk of adverse outcomes, with 125 g/L being the reference point for lowest risk.

\n

Q2: Why is the finding about high hemoglobin (erythrocytosis) significant?

\n

High Hb levels, such as 150 g/L, carried an adjusted Relative Risk (aRR) of 1.20 for SNM-M, which was higher than the risk associated with moderate anemia (105 g/L). Therefore, this highlights the danger of potential over-correction or excessive iron status, suggesting clinicians should aim for a true optimal range, not just the upper limit of normal. Moreover, a systematic review also supports a nonlinear association between Hb and adverse outcomes.

\n

Q3: How does this impact iron supplementation in India?

\n

India has a high prevalence of anemia and national guidelines recommend universal Iron and Folic Acid (IFA) supplementation. However, this new data suggests that the goal should be a precise correction rather than aggressive over-supplementation that could lead to relative erythrocytosis in some women, which itself poses a risk. Future RCTs are needed to define optimal iron therapy protocols.

\n

References

\n

\n
1. Shams I et al. Hemoglobin Concentration in Early Pregnancy and Severe Neonatal Morbidity and Mortality : Population-Based Cohort Study. Ann Intern Med. 2026 Feb 03. doi: 10.7326/ANNALS-25-02586. PMID: 41628471.
\n
2. Kumar A et al. Prevalence of anemia in pregnant women and its effect on neonatal outcomes in Northeast India. J Matern Fetal Neonatal Med. 2014 Jun;27(9):887-91.
\n
3. Molla M et al. Maternal anaemia and risk of adverse obstetric and neonatal outcomes in South Asian countries: A systematic review and meta-analysis. Ann Med Surg (Lond). 2020 Mar;51:115-120.
\n
4. Zhao M et al. Effects of hemoglobin levels during pregnancy on adverse maternal and infant outcomes: a systematic review and meta‐analysis. Int J Gynaecol Obstet. 2025 Aug 06;150(2):220-230.
\n
5. Management of Iron Deficiency Anemia in Pregnancy in India. Indian J Hematol Blood Transfus. 2018 Mar;34(1):1-10.
\n